-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Keros Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2019 to Q1 2024.
- Keros Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$44.6M, a 30.2% decline year-over-year.
- Keros Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$125M, a 77.7% decline from 2022.
- Keros Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$70.1M, a 12.7% decline from 2021.
- Keros Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$62.1M, a 68.5% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)